ENSC

Ok-Macaron9014

ENSC is slowly climbing.

ItsDana-

ENSC making a come back GFAI going up earnings on Monday

DoxxedAccount321

Do stocks even start to explode during market open? For a while, I noticed that they start either during PM or AH (e.g. ENSC earlier) and their behavior at the start of open market really make me nervous

Sensitive-Alfalfa-66

ENSC looking like a lovely reversal play

Federal_Egg_3581

ENSC - Before it's too late [https://www.barchart.com/story/news/32006942/ensysce-biosciences-receives-us-patent-for-groundbreaking-treatment-of-opioid-use-disorder](https://www.barchart.com/story/news/32006942/ensysce-biosciences-receives-us-patent-for-groundbreaking-treatment-of-opioid-use-disorder)

Ok_Employment_192

mmm ENSC is very tempting, but I have to wait till market open . Guys what do you think? It is still worthwhile a gamble? Or now it is too late and the party will be over soonish?

TobiasGilmore

ENSC shoutout Beaver pelt for leading me to play Pro Ticker choices

Ok-Macaron9014

ENSC

Sianger

So my pharma play yesterday ENSC spent most of AH/PM/today just slowly losing value. Do y'all think the same will happen for BCTX and MIRA? holding some bags there from PM today when they seemed promising (and I bought in high)...

Behold-Judge-Holden

Anyone holding bags of ENSC? I saw the low float after someone shouted it out ... but I'm curious if anyone thinks it's going to go back up. PM has been a slow bleed.

Behold-Judge-Holden

Anyone got some speculation on ENSC? I was hearing about low float and good news, but nothing really else apart from that.

c-74

Why did $ENSC jump AH ?

swordofomens94

ENSC going

cremeegggorilla

ENSC popped. Took 30%

Sianger

Boring day for those of us not on the SUNE train... but yeah ENSC looks promising

cremeegggorilla

ENSC is starting to heat up if anyone's out of SUNE

chiisushedjiddb

ENSC looking good

cremeegggorilla

ENSC and SUNE looking good

chiisushedjiddb

https://www.stocktitan.net/news/ENSC/ensysce-biosciences-announces-positive-data-from-opioid-overdose-69ir17v7mbhe.html “Only opioid product with FDA's Breakthrough Therapy designation” Gonna put a bit in ENSC. Pretty good news with a tiny float

udhjdubcmj

Short $ENSC

Hlomney

Short $ENSC

QuirkyAverageJoe

Huge dump $ENSC

QuirkyAverageJoe

Short $ENSC

JJdisco21

Yessir! I cannot tell you which ones, I’ve probably played at least 100 in the past 2 months. Recent memory: FOXO RGTI IDAI OPTT JXAI ENSC JFBR

Jintopia

ENSC 📈🐌💪🏽🚀

GoStockYourself

ENSC

SeaSongJac

- BFLY : digital health company focused on providing portable, semiconductor ultrasound units - BCTX: cancer immunotherapy with one in Phase 3, FDA fast tracked and beating current therapies for breast cancer. Way undervalued, in my opinion - ENSC: Potential solution for pain other than opioids

ComfyRug

Ensysce Biosciences, Inc. (ENSC) is currently experiencing heightened speculative interest, with potential short squeeze activity driving recent price volatility. The stock has seen a significant increase in volume and price, moving from $0.33 to $0.84 over the past month, indicating strong buying pressure possibly linked to short covering. Technical indicators show bullish momentum, with the current price well above the 10-day SMA of $0.49 and the MACD histogram positive, suggesting continued upward movement. However, the RSI near 60 indicates the stock is approaching overbought territory, warranting caution. Given the broader market’s bullish sentiment, ENSC could see further gains if momentum persists. For today’s session, consider a long position with an entry around $0.82, targeting $0.95 as the first target and $1.05 as the second, with a stop loss at $0.75. Confidence in reaching the first target is moderate due to current momentum, but the second target carries higher risk given potential volatility and lack of fundamental catalysts.

GoStockYourself

ENSC

IndependenceSome5989

Buy ENSC

TehPwnStar

Hedge Fund just bought 10% of ENSC bio last night. Here comes the next DRUG. Get on the bandwagon. $.60 > $10 this week. Easy money.

TehPwnStar

Here we go y’all. A hedge fund just came in and bought 9% of ENSC yesterday. Be prepared For the ride up! Give the post some ups so others can help the volume and awareness. This is going to be like DRUG and get up to $10-&12 at the lowest.

TehPwnStar

ENSC is my favorite that I watch closely. I don’t have any other suggestions :-( It should hit .80 a .90 tomorrow early and then drop back down.

DVCatfishCowboy

I got a feeling ENSC is gonna hit the moon tomorrow or sometime this week. Medical stocks have been HOT since last week. Biotechs, biopharms, gene therapies, etc…

ComfyRug

EOSE: Eos Energy Enterprises, Inc. (EOSE) is currently trading at $3.12, showing a consolidation pattern after a recent rally from the $2.50 level. The 10-day SMA at $3.18 and the 8-day EMA at $3.19 suggest a short-term resistance, while the RSI levels indicate neutral momentum, providing room for potential upside. The MACD histogram is slightly negative, hinting at a possible pullback, but the broader market's cautious optimism and strength in technology sectors could support EOSE's upward movement. Given the lack of significant news, technical indicators will likely drive today's action. I recommend entering a long position around $3.10, with a first price target of $3.25 (moderate confidence) and a second target of $3.35 (lower confidence), setting a stop loss at $3.00 to manage downside risk. This strategy aligns with the current market sentiment and EOSE's technical setup, offering a balanced risk-reward profile for day traders. ENSC: Ensysce Biosciences, Inc. (ENSC) is experiencing significant momentum, with a current price of $0.505 and a recent surge in volume, indicating strong buying interest. The RSI levels are extremely overbought, suggesting potential for a pullback, but the MACD histogram shows bullish momentum. The stock has broken past its 30-day SMA of $0.2609, signaling a strong upward trend. Given the broader market's cautious optimism, ENSC could benefit from continued interest in growth sectors. For today's session, consider entering around $0.50, with a first target at $0.55 and a second target at $0.60, while setting a stop loss at $0.45 to manage risk. Confidence in reaching the first target is high due to recent volume spikes and technical breakouts, while the second target carries moderate confidence given potential volatility. Keep an eye on any sudden shifts in market sentiment or unexpected news that could impact this micro-cap stock. HUMA: Humacyte, Inc. (HUMA) is facing significant headwinds due to an ongoing investigation into potential federal securities law violations, which has already impacted its FDA application and manufacturing capabilities. The stock's technical indicators show a mixed picture: the MACD histogram is slightly positive, suggesting weak bullish momentum, while the RSI hovers around neutral, indicating indecision. Recent trading volumes have been erratic, with a notable spike in volatility, reflecting investor uncertainty. Given the broader market's cautious optimism, HUMA may not align with the tech-driven strength seen in indices like QQQ. For today's session, expect potential downside pressure; consider entering a short position around $5.50. Set a first price target at $5.30 and a second at $5.10, with a stop loss at $5.60 to manage risk. Confidence in these targets is moderate due to the unpredictable nature of legal investigations and their impact on stock sentiment. RILY: B. Riley Financial, Inc. (RILY) is showing signs of bullish momentum, with the current price at $5.98, above key moving averages (10-day SMA at $5.31 and 8-day EMA at $5.64), indicating a potential continuation of the upward trend. The MACD histogram is positive, suggesting increasing buying pressure, while the RSI levels are approaching overbought territory, which could signal a short-term pullback. Given the broader market's cautious optimism, RILY may benefit from the strength in growth-oriented sectors. For today's session, consider entering a long position around $5.95, with a first price target of $6.30 and a second target of $6.50, supported by recent highs. Set a stop loss at $5.75 to manage downside risk. Confidence in reaching the first target is moderate due to strong technical indicators, while the second target carries lower confidence given potential market volatility. Keep an eye on volume spikes as they could confirm the breakout.

Affectionate_Disk_68

$ENSC has 750 Million shares traded today. Def a pump and dump but I've never seen volume that high, ever.

grim_exe_

ENSC, okay we see you 

DaOneBoiYOLO

ENSC - Ensysce Biosciences It used to be worth alot now its a penny stock. This could end up being a 1000%+ if pumped as it has very low market cap right now and low daily trade volume under 100k so if it gets noticed and people pump the stock it could go insanely high if you look at what it used to he priced at

wallstreetguru_

Green for the next week will be ENSC and CDZI ya heard these are moving with not that much volume but still enough for liquidity. If either of these trade over 1m shares they will be +40% easy

wallstreetguru_

Ensysce BioSciences or Nasdaq: ENSC

Mongoose_player

ENSC hawt chick at the prom ill ride it

wallstreetguru_

ENSC has is super low float and has potential to hit $2. Im so ready for this ticker

Snoo-40125

Ah ENSC….back from the depths of hell haha

BLAKEEMM

ENSC potential 50 bagger in two years. TCON potential 5 bagger in 3 weeks  Place your bets 

Polecatt4200

YES! When you can help end the Opiate Epidemic w/ $ENSC... Rock bottom price, second leg of a double bottom on a 5 year chart. Nearly the same price & FDA approval will be by March 24th...

Level_Inflation_8408

ASLN, NKGN, GRI, TPET, TCBP, RVSN, VLD, YOSH, ENSC, and just maybe FSR. look into it my G

Level_Inflation_8408

currently looking into ENSC & NKGN, have not made a decision yet. Primary drive is #TCBPTakeOff 🧬🌙 just bought even more shares about an hour ago 🦠🔬

BLAKEEMM

Watch out ENSC

BLAKEEMM

ENSC  2 year 300 bagger 

BLAKEEMM

Get in ENSC . 50X incoming. No worries about squeezing 

BLAKEEMM

ENSC 50X by year end

BLAKEEMM

You want a 50 bagger??? ENSC and thank me after a year 

UnhappyHotel5099

Hot Stock To Check Out- FDA Breakthrough Therapy Heading to Phase III  I did some research - please take a look as this could explode over the next year!! https://ensysce.com/ Ensysce Bioscience- ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer.  ENSC has a niche to help/solve the Opioid Crisis that gets worse every day.   Basically they have something that no one else has- niche market and  FDA approval happens the price will skyrocket! $ENSC  The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years.  3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come… $ENSC Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well. This is their partners website - https://oncozenge.se

UnhappyHotel5099

Hot Stock To Check Out- FDA Breakthrough Therapy Heading to Phase III  I did some research - please take a look as this could explode over the next year!! https://ensysce.com/ Ensysce Bioscience- ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer.  ENSC has a niche to help/solve the Opioid Crisis that gets worse every day.   Basically they have something that no one else has- niche market and  FDA approval happens the price will skyrocket! $ENSC  The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years.  3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come… $ENSC Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well. This is their partners website - https://oncozenge.se

UnhappyHotel5099

Hot Stock To Check Out- FDA Breakthrough Therapy Heading to Phase III  I did some research - please take a look as this could explode over the next year!! https://ensysce.com/ Ensysce Bioscience- ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer.  ENSC has a niche to help/solve the Opioid Crisis that gets worse every day.   Basically they have something that no one else has- niche market and  FDA approval happens the price will skyrocket! $ENSC  The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years.  3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come… $ENSC Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well. This is their partners website - https://oncozenge.se

UnhappyHotel5099

Hot Stock To Check Out- FDA Breakthrough Therapy Heading to Phase III  I did some research - please take a look as this could explode over the next year!! https://ensysce.com/ Ensysce Bioscience- ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer.  ENSC has a niche to help/solve the Opioid Crisis that gets worse every day.   Basically they have something that no one else has- niche market and  FDA approval happens the price will skyrocket! $ENSC  The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years.  3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come… $ENSC Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well. This is their partners website - https://oncozenge.se

UnhappyHotel5099

Hot Stock with FDA Breakthrough Designation!!!!  Ensysce Bioscience- ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer. ENSC has a niche to help/solve the Opioid Crisis that gets worse every day. Basically they have something that no one else has- niche market and FDA approval happens the price will skyrocket! $ENSC The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years. 3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come… $ENSC Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well. This is their partners website - https://oncozenge.se  https://ensysce.com

UnhappyHotel5099

The opioids crisis continues to be a plague on society - they have Breakthrough Therapy Designation- which very few drug therapies get.  Hopefully with that because they review results as they come in by the end of the year early next year they could go to market.   Also, below is another collaboration. They have with a Swedish Pharma company that could be huge as well.  We just need to continue to push the word on Reddit to get more people aware of what ENSC is doing and potential. $ENSC  Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well.  This is their partners website - https://oncozenge.se

MaSupaCoolName

So ENSC could be a long term buy... I dont know FDA timing for approval, but reading your post and doing some research about Phase 3 it could be in 1 or 2 year from now, right? I see the price is pretty low now, do you think it could be lower?

UnhappyHotel5099

ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer.  ENSC has a niche to help/solve the Opioid Crisis that gets worse every day.   Basically they have something that no one else has- niche market and  FDA approval happens the price will skyrocket! $ENSC  The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years.  3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come…

yoyo1time

LAES, ENSC ICU. ICU is going to run. 100 percent plus. 2 catalysts this week coming

Gtron011212

I also had the please of watching ENSC going down 25% since yesterday. Also a hype by. But this one is holding a little more stable. Wish me luck lol

EllisDee3

I missed that $ENSC pump this morning. Feel wrecked.

Market___Maker

No one is looking on $ENSC but I think this gonna skyrocket for a few folds imo

yoyo1time

Im new here— i got kicked out of short squeeze because the mod said i belong here— any way— here are solid ideas. Not all will be possible, but will be profitable if you can enter at these levels 1. LAES 1.58 2. PHUN. .22 3. ICU .65 4. ENSC 1.40 5. RUM 5.35 All entries are possible—- maybe all next week. A month from now, this post is worthless. But any should yield 20-50 percent next week—swing trade style

bogeybank

Whats going on with $ENSC and $BCLI?

wavychaser

It's definitely ENSC - I don't really understand the product and it's a little high for me but I think it does have potential, at least the opioid epidemic could use some help. I'm bullish on psychedelics, even for addiction!

Theo_011

This one could hit $2 in a week and still be cheap based on existing trials and the market available. ENSC could be a huge solution for the opioid crisis in the world. ENSC has a better product than oxycodone, with very little chance of OD.

BILLYTHEGOATG

$ENSC - VERY Undervalued. Currently $1.6, price target $9-$18 by HC Wainwright & Co. Analysis. News Oct. 19th, 2.7 mil float. Also broke the downtrend and has just started the curl upwards

i_dont_really_care4

I’m going in on ENSC. Volume is high on no real news, hoping Monday it pops off.

BUDDHA_LAUGHING

My eyes are on ENSC, BWV, and HLGN but I think it's early for them, not buying just yet.

IHateSilver

Thanks for answering my thread about CVNA , I appreciate it. I had mentioned that I would throw everything else into some bio stocks (ENSC, CVAV, NWBO) but I had luck in the past with VBIV (got some options for Jan 24). It’s not a squeeze per say play but I believe that this stock is insanely undervalued. Would love to hear your thoughts about VBIV. It’s still somewhat under the radar but slowly keeps getting more attention. Thanks

Feisty-Juan

I bought all the small pharma stocks in 2022. I’m never getting my money back from ENSC, DNA, GSM or OCGN so I’ll be ignoring all the next miracle cure makers for the rest of my life savings

drewjamesSB

ENSC been waiting on this one for a while! If the VA gets involved it will be something special! Helps people combating addiction to pain killers. It’s been death spiral financing was over $11 a few months ago and now under a buck is a steal.

Drippyangel3

Going in on $ENSC

StockyJ122

>ENSC All of that just because of a phase 1 initiation?

Traditional-Exit8554

ENSC today. They have a drug that blocks overdoses and regulates oxycodone release. Can’t crush, chew, snort, oxy . Conference sometime today I believe

PolarBell

ENSC

IHateSilver

Well, today was a fucking nightmare. On top of the damn HKD disaster sold a all my ENSC holdings after seeing another SRC filling, assuming it was another dilution. My average was .63 and I really believe in their opiate OD blocker...oh and the cost to borrow was around 550. Not a good day but there's always tomorrow. Can't be emotional like I was today, it really screw's things up. I'm still holding the P&D but hope I will at least come close to even. From now on I will only concentrate in small cap bio stocks, preferably Covid related. For others bin the same sinking ship, good luck today!

BUDDHA_LAUGHING

No problem. Not financial advice but watchlist recommendations: GOVX, ENSC, NRSN and AUVI. I'm watching closely for added volume and/or news.

Professional_Ask6692

ENSC looks…interesting. Already had a RS in October. Not impressed with the volume, but the float,CTB rate and the coming results in March of the drug trial, announced as complete yesterday, has my attention.

BUDDHA_LAUGHING

I'm so bad at predicting. It seems I am usually spot on the day of the squeeze like today with BOXD (though I deleted that post for various reasons) or I'm three weeks early, occasionally up to six. With the high CTB you would think it would be soon, but ENSC has been in the same situation and is taking its own sweet time.

Suresh_74

ENSC ?

catsmom63

ENSC information from you spoke about it?

Professional_Ask6692

ENSC…announced today phase 2 completed, %546 CTB W/100k available.

Professional_Ask6692

ENSC has my attention. GL

Joeyc08

$ENSC

IHateSilver

Thanks, today was a strange day. ENSC kept going down for quite a while and today went up 20 percent.

IHateSilver

That just happened. I researched bio stocks that have an interesting pipeline and they came up. ENSC was a bit over $2 right before I bought it, then they did an offering and it dumped. Today it went up 20 percent for once.

Equivalent-Injury-52

Good dd on those stocks. Nice pick on ENSC I see it is doing good.

Equivalent-Injury-52

Good dd on those stocks. Nice pick on ENSC I see it is doing good .

BUDDHA_LAUGHING

ENSC happening now. Not financial advice.

IHateSilver

I'm in 3 bio stocks right now and feel pretty good about it. It's not a short squeeze (maybe one since the short selling fee is 647.56%) They are all penny stocks 1: ENSC —high borrow fee but had/has quite a bit of dilution I bought in at .63 because I like what the company is working on...Ensysce’s proprietary MPAR™ (Multi-Pill Abuse Resistance) technology can turn off the activation when too much TAAP medication is taken. This does not affect the effectiveness of MPAR™ products when taken as prescribed. 2: Northwest Biotherapeutics Inc— OTCMKTS: NWBO Northwest Biotherapeutics, Inc is a clinical stage biotechnology company focused on the development of personalized cancer vaccines designed to treat a broad range of solid tumor cancers. They are also in the midst of a lawsuit against stock price manipulation by short sellers. Got in at .83 3: VBIV https://www.vbivaccines.com Has a Hep C vaccine FDA approved Also received 33 million funding from the Coalition for Epidemic Preparedness Innovations to develop a multivalent vaccine against Covid 10 and other coronaviruses. This stock is at its 52 week low at .38 Huge upsides on all three with minimal downside at least in my opinion.

l1lturbo

Watching $ENSC $IMTE

IHateSilver

▫️VBIV: -Receives U.S. FDA Orphan Drug Designation for VBI-1901 for the Treatment of Glioblastoma. -FDA just approved their Hep B vaccine: PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] is the only approved 3-antigen hepatitis B vaccine for adults in the U.S. -The Coalition for Epidemic Preparedness Innovations (CEPI) is expanding its world-leading portfolio of potential variant-proof coronavirus vaccines in a deal with VBI Vaccines Inc. (Nasdaq: VBIV) to advance the development of multivalent coronavirus shots that could be deployed against COVID-19 as well as a future ‘Coronavirus X’. ▫️ENSC: -Stock tumbles 49% during pre-market. That was a few days ago but it's still down due to the offering. Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. -prices an underwritten public offering of 2.9M shares and warrants to purchase up to an aggregate of 5.8M shares at a combined price of $1.40 per share of common stock and accompanying warrants. Each warrant is exercisable immediately at an exercise price of $1.40 per share and will expire five years following the date of issuance. Company expects to receive aggregate gross proceeds of ~$4.1M. Offering is expected to close on or about December 9, 2022. Underwriter's 45-day option to purchase up to an additional 342,000 shares and/or warrants to purchase up to an additional 870,000 shares. 20% of the gross proceeds will be used to repay a portion of the company's outstanding convertible notes. Remaining proceeds for the further clinical development of its product candidates.

BuckeyeSV

Uhm, so I've been doing a little DD on it and to be fair, I don't really know my ass from a hole in the ground but thankfully I know how to read and I can also type so I can ask Google questions when I am confused.... So I tell you all that to tell you, I don't think an offering is going to be good in the short term. If this is a play, I feel like it's a play that is a ways off, like when their drug actually makes it to market. And again, I don't know shit....but their earnings appear to look like shit, the company currently isn't profitable. But again, idk 🤷 BUT....for a grand finale....I want to mention QTNT. In ENSC third quarter finances, they mentioned a partnership with QTNT. Which is currently trading at .60 some cents and is a bottomed out chart. Had a 52 week high of 112. If ENSC DOES pop, so will this little guy. Something to look out for

MungerMentalModel

When will the dilution be reflected in the ENSC share price?

BuckeyeSV

Addiction overdose pain?? Tf is that bro?!😂😂 You ain't never been addicted to heroin and it really shows... Idk who produces methadone, or the newest one Suboxone. But whatever drug ENSC is making is supposed to rival those two

PresentSky1080

I'm down 33% I was down 45% but in last month or so I'm up 10% mainly because of USEA got in at 1.65 and timing and playing COMS COSM hlbz. Now I'm looking at ENSC low float high si positive trials for opioid addiction overdose and pain. Public offering at 1.40 for 2.9 Mill shares and warrants 5.8mill at 1.40 expire 5 years from aggregate date

IHateSilver

ENSC